News | December 04, 2024
Biocon celebrates 46th Founder’s Day
The celebrations began with the unveiling of the Biocon Anthem
The celebrations began with the unveiling of the Biocon Anthem
She will be responsible in this role for Finance & Controlling, HR Services and IT Management at Romaco Holding
The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Xalatan
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
New research labs and process development services to enable next generation therapeutics
Dr. Muthu was last associated with Mankind Pharma
Bringing a new drug to market takes about 10 years and requires an investment of approximately $1 billion
Subscribe To Our Newsletter & Stay Updated
